CEO
Liron Carmel
Employees
26
Industry
Surgical and Medical Instrument Manufacturing
medical device company focused on innovative endoscopic procedures and devices. medigus developed an entire endoscopic system for intraluminal treatment of gerd (gastroesophageal reflux disease), one of the most common chronic diseases in the western world. the endoscopic system for the treatment of gerd - the srs - combines a miniaturized video camera, a surgical stapler and ultrasonic sights for alignment in a single instrument. the srs system and its unique flexible endoscope allows gastroenterologists and surgeons to perform endoluminally a true partial anterior fundoplication, thereby revolutionizing the treatment of gerd by eliminating the need for open or laparoscopic surgery - the current standard practice for treating severe gerd. shifting the gerd treatment from surgery to an endoluminal procedure, without opening the abdominal cavity, is a revolution. in addition, medigus designs and manufactures endoscopy systems for partner companies based on its proprietary technologies,
Loading...
Open
2.21
Mkt cap
4.5M
Volume
26K
High
2.58
P/E Ratio
-0.27
52-wk high
7.17
Low
2.17
Div yield
N/A
52-wk low
1.54
Portfolio Pulse from Benzinga Insights
April 09, 2024 | 8:31 pm
Portfolio Pulse from Benzinga Newsdesk
April 09, 2024 | 8:06 pm
Portfolio Pulse from Benzinga Newsdesk
March 27, 2024 | 12:02 pm
Portfolio Pulse from Benzinga Newsdesk
January 04, 2024 | 12:53 pm
Portfolio Pulse from Benzinga Newsdesk
December 18, 2023 | 1:48 pm
Portfolio Pulse from Benzinga Insights
November 24, 2023 | 1:06 pm
Portfolio Pulse from Benzinga Newsdesk
November 22, 2023 | 3:14 pm
Portfolio Pulse from Benzinga Newsdesk
November 13, 2023 | 12:56 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.